Staff

Recce Pharmaceuticals Announces Encouraging Preliminary Results from Antiviral Screening Program at The Doherty Institute Evaluating RECCE® 327 Against SARS-CoV-2

Virus Titers IC50 of test compound excluding the three lowest data points: 109.8 PPM. Data as extracted from Doherty Institute...

error: Content is protected !!